Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Importance of Standardized Nomenclature to Advance Hidradenitis Suppurativa Research and Clinical Care.

Literature DB >> 33688911

Importance of Standardized Nomenclature to Advance Hidradenitis Suppurativa Research and Clinical Care.

Haley B Naik¹.

Abstract

Entities: Chemical

Mesh：

Year: 2021 PMID： 33688911 PMCID： PMC8163030 DOI： 10.1001/jamadermatol.2020.5466

Source DB: PubMed Journal: JAMA Dermatol ISSN： 2168-6068 Impact factor: 10.282

Keyword Cloud
References

× No keyword cloud information.

14 in total

Review 1. New insights into the diagnosis of hidradenitis suppurativa: Clinical presentations and phenotypes.

Authors: Hessel H van der Zee; Gregor B E Jemec
Journal: J Am Acad Dermatol Date: 2015-11 Impact factor: 11.527

2. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity.

Authors: C C Zouboulis; T Tzellos; A Kyrgidis; G B E Jemec; F G Bechara; E J Giamarellos-Bourboulis; J R Ingram; T Kanni; I Karagiannidis; A Martorell; Ł Matusiak; A Pinter; E P Prens; D Presser; S Schneider-Burrus; E von Stebut; J C Szepietowski; H H van der Zee; S M Wilden; R Sabat
Journal: Br J Dermatol Date: 2017-10-30 Impact factor: 9.302

Review 3. A systematic review of terms used to describe hidradenitis suppurativa.

Authors: M Freysz; G B E Jemec; D Lipsker
Journal: Br J Dermatol Date: 2015-08-12 Impact factor: 9.302

4. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.

Authors: L Thorlacius; A Garg; P T Riis; S M Nielsen; V Bettoli; J R Ingram; V Del Marmol; L Matusiak; J C Pascual; J Revuz; K Sartorius; T Tzellos; H H van der Zee; C C Zouboulis; D M Saunte; A B Gottlieb; R Christensen; G B E Jemec
Journal: Br J Dermatol Date: 2019-06-06 Impact factor: 9.302

5. The ABC of Hidradenitis Suppurativa: A Validated Glossary on how to Name Lesions.

Authors: Dan Lipsker; François Severac; Marie Freysz; Eric Sauleau; Jurr Boer; Lennart Emtestam; Łukasz Matusiak; Errol Prens; Charles Velter; Cédric Lenormand; Nicolas Meyer; Gregor B E Jemec
Journal: Dermatology Date: 2016-02-19 Impact factor: 5.366

10. HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study.

Authors: A B Kimball; J M Sobell; C C Zouboulis; Y Gu; D A Williams; M Sundaram; H D Teixeira; G B E Jemec
Journal: J Eur Acad Dermatol Venereol Date: 2015-07-22 Impact factor: 6.166

Importance of Standardized Nomenclature to Advance Hidradenitis Suppurativa Research and Clinical Care.

Review 1. New insights into the diagnosis of hidradenitis suppurativa: Clinical presentations and phenotypes.

2. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity.

Review 3. A systematic review of terms used to describe hidradenitis suppurativa.

4. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.

5. The ABC of Hidradenitis Suppurativa: A Validated Glossary on how to Name Lesions.

6. Proposed Definitions of Typical Lesions in Hidradenitis Suppurativa.

Review 7. Hidradenitis Suppurativa: Advances in Diagnosis and Treatment.

8. A Call to Accelerate Hidradenitis Suppurativa Research and Improve Care-Moving Beyond Burden.

9. A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process.

10. HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study.